Conversion Disorder (Functional Neurological Symptom Disorder)

Conversion Disorder — officially renamed Functional Neurological Symptom Disorder (FND) in DSM-5 — causes genuine, involuntary neurological symptoms (weakness, paralysis, seizures, tremor, sensory loss, speech and vision problems) that cannot be explained by structural neurological disease. The condition affects 4–12 people per 100,000 per year and accounts for approximately 16% of neurology outpatient consultations, making it the second most common reason for a neurology visit after headache. Patients are not fabricating symptoms. The symptoms are real, distressing, and often severely disabling. Modern neuroimaging has revealed specific brain network abnormalities that distinguish FND from malingering and from organic neurological disease. The historical term "hysteria" was both inaccurate and harmful; the preferred term FND describes a functional brain network disorder, not a psychosomatic weakness.

Overview, History, and Terminology
Epidemiology: How Common Is FND?
Pathophysiology: The Predictive Coding Model
Neuroimaging Evidence
Common Presentations: Weakness, Seizures, Tremor, and More
Psychogenic Non-Epileptic Seizures (PNES)
Positive Diagnostic Signs on Clinical Examination
Investigations and Gold-Standard Diagnosis
Treatment: Psychoeducation and Physical Therapy
Psychological Treatments: CBT, EMDR, and Inpatient Rehabilitation
Prognosis and Recovery
Key Research Papers
Featured Videos

1. Overview, History, and Terminology

The history of what we now call Functional Neurological Symptom Disorder is a history of misunderstanding, stigma, and slow scientific progress. The term "hysteria" derives from the Greek hystera meaning uterus — ancient physicians believed that the uterus wandered throughout the body, causing a variety of symptoms wherever it lodged. This profoundly misogynistic framework was applied exclusively to women and persisted in various forms for over two millennia. The word itself encodes a clinical prejudice that caused immeasurable harm to patients whose genuine suffering was dismissed as feminine weakness, moral failing, or attention-seeking.

Jean-Martin Charcot, the founder of modern neurology, practiced at the Salpêtrière Hospital in Paris during the late 19th century and brought rigorous clinical observation to what he called "hysteria." He demonstrated hysterical symptoms at public theatrical demonstrations — elaborate clinical theater that simultaneously advanced observation (Charcot correctly identified that these symptoms followed consistent patterns and could be reliably demonstrated) and deepened stigma (the performances transformed patients into spectacles). Charcot's student Sigmund Freud developed the concept of "conversion" — the idea that unconscious psychic energy, unable to find normal expression, was "converted" into a physical symptom. This gave the disorder its name of Conversion Disorder, but Freud's hydraulic model of the mind is now considered an oversimplification unsupported by neuroscience.

The DSM-III (1980) retained the term "Conversion Disorder" and placed it within the category of somatoform disorders. The DSM-5 (2013) made a landmark revision: the condition was renamed "Functional Neurological Symptom Disorder," and critically, the diagnostic criteria were overhauled. DSM-5 requires POSITIVE neurological signs that demonstrate internal inconsistency (see Section 7), rather than merely the absence of an organic explanation. Equally important, DSM-5 removed the requirement for a preceding psychological stressor — a stressor is not needed for diagnosis. This change reflects the clinical reality that many FND patients have no identifiable trauma or stress history. The ICD-11 uses the term "Dissociative neurological symptom disorder" — a different nomenclature reflecting the ICD's emphasis on the dissociative features of FND — creating some cross-system terminology confusion that clinicians must navigate.

The modern understanding of FND frames it as a disorder of brain network function — accurately described as a "software problem rather than a hardware problem." The neural circuits, wiring, and structures are largely intact; the problem is in how those circuits are operating. This framing is both scientifically accurate and clinically helpful: it explains why neuroimaging scans appear normal (the hardware is fine), why symptoms can fluctuate and respond to non-pharmacological interventions (the software can be reprogrammed), and why the disorder is real and not imagined (the brain is genuinely running a faulty program). This reframing has substantially reduced stigma and improved clinical communication.

2. Epidemiology: How Common Is FND?

Functional Neurological Symptom Disorder is far more common than is generally appreciated. The annual incidence is estimated at 4–12 per 100,000 per year (Stone 2012), with a point prevalence of approximately 50 per 100,000 — comparable to the combined prevalence of multiple sclerosis and Parkinson's disease. FND accounts for approximately 16% of neurology outpatient consultations, making it the second most common reason to see a neurologist after headache. Despite this epidemiological significance, FND receives a fraction of the research funding, academic attention, and clinical training investment directed at MS or Parkinson's disease.

Psychogenic Non-Epileptic Seizures (PNES) — the most clinically urgent FND variant — affects an estimated 150,000–400,000 Americans. Studies consistently find that 20–40% of patients admitted to epilepsy monitoring units for "refractory epilepsy" actually have PNES rather than epileptic seizures. The mean time from first PNES event to correct diagnosis is 7–10 years, during which most patients receive anti-epileptic drugs (AEDs) that are entirely ineffective for PNES while causing significant side effects including cognitive impairment, weight gain, teratogenicity in women of childbearing age, and reduced bone density. The mean number of emergency department visits before correct diagnosis is approximately 8 per patient.

The demographics of FND show a female-to-male ratio of approximately 3:1 for most FND subtypes, with PNES showing an even higher female predominance of 70–80%. The mean age of onset is in the 30s to 40s, though FND occurs at all ages from childhood through late life. Childhood FND is increasingly recognized and carries specific management considerations. The female predominance has historically been used to reinforce the stigmatizing "hysteria" framing; modern researchers emphasize that FND in men is underrecognized and that the sex ratio likely reflects complex interactions between sex-linked stress response patterns, healthcare-seeking behavior, and historical diagnostic bias.

The societal costs of FND are substantial and largely invisible. Diagnostic delay of 7 years means years of ineffective treatment, unnecessary testing, accumulated side effects, and progressive disability. There is substantial overlap between FND and other functional somatic syndromes — fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and chronic pain — suggesting shared central sensitization mechanisms and a common vulnerability in neural self-regulation. Many FND patients carry multiple functional diagnoses before receiving a unified FND framework that explains all their symptoms under one mechanistic model.

3. Pathophysiology: The Predictive Coding Model

The most influential current model of FND pathophysiology is the predictive coding framework, developed and elaborated by Mark Edwards, Jon Stone, and colleagues at University College London and the University of Edinburgh. The brain, in this model, is fundamentally a predictive organ: it does not passively receive sensory input and react — it generates constant top-down "predictions" about incoming sensory information and motor output, then compares these predictions to actual incoming signals. Discrepancies — "prediction errors" — drive learning and updating of predictions. This framework, supported by Bayesian models of brain function, explains a broad range of perceptual and motor phenomena.

In FND, the predictive coding mechanism operates abnormally. Abnormally strong or abnormally weighted top-down predictions — "I cannot move my arm," "This limb is not mine," "This sensation is absent" — override bottom-up motor commands or sensory input. The brain's predictive system suppresses movement because it has over-weighted the prediction of motor failure or sensory loss. The result is a genuine motor deficit or genuine sensory disturbance: the brain is physically implementing a faulty prediction. This is not the same as "imagining" symptoms, consciously or unconsciously — the predictive mechanism operates largely outside voluntary control, at a level of neural processing that is automatic and pre-conscious. The patient is not choosing to suppress movement; the predictive system is doing it for them.

A critical feature of FND is the role of self-directed attention. When a patient directs attention toward the affected body part — monitoring for weakness, watching for tremor, attending to sensory loss — this self-directed attention creates a feedback loop that reinforces the abnormal prediction. Internal attentional focus on the limb amplifies the predictive error and deepens the symptom. This mechanism directly informs treatment: physical therapy for FND explicitly uses external focus techniques (attending to an external target rather than the limb itself) and automatic movement strategies, because these reduce the internal attentional feedback loop that maintains FND symptoms.

The role of trauma and stress deserves careful framing. Studies consistently find that 50–70% of FND patients have a history of physical, sexual, or emotional abuse. However, this is not a universal or required finding — many FND patients have no trauma history whatsoever. A peripheral injury (a minor ankle sprain, a car accident with no significant physical injury) can trigger FND onset in susceptible individuals: the injury provides a "template" for the abnormal prediction, anchoring the brain's predictive system around an injury model even after healing has occurred. Disturbances of agency and volition are also measurable in FND: patients experience either passive agency (movements happen without a sense of "I chose to do that") or volition failure (failure to move without a sense of "I tried and was blocked by weakness"). These disturbances overlap with measurable disruptions in normal motor control circuitry and are not metaphors — they reflect specific impairments in the cortical systems that mediate voluntary action.

4. Neuroimaging Evidence

A substantial body of functional neuroimaging (fMRI, PET, SPECT) has now characterized FND-specific brain network patterns, providing the neurobiological evidence base that distinguishes FND from organic neurological disease and from malingering. These findings are group-level patterns and cannot yet diagnose individual patients, but they are mechanistically informative and important for clinician and patient education.

The most consistent finding in functional motor weakness is reduced connectivity between the supplementary motor area (SMA) and the primary motor cortex (M1) during attempted movement. The SMA — a region critical for motor planning, intention, and the initiation of voluntary movement — fails to communicate normally with M1 (the execution site of motor commands) when FND patients attempt to move the affected limb. This neural disconnection provides a mechanistic substrate for the experience of "trying to move but nothing happening" that patients describe. In malingering, by contrast, the SMA-M1 connectivity pattern is preserved — the person is actively suppressing motor output through a different mechanism involving deliberate inhibition of movement planning.

Abnormal prefrontal-motor connectivity is a second major finding. The prefrontal cortex — responsible for emotional regulation, prediction, attention, and executive function — shows abnormal hyperconnectivity with motor regions in FND. This is consistent with the predictive coding model: the prefrontal cortex is implementing the top-down "prediction" of motor failure, and its excessive communication with motor regions is the neural substrate of that suppressive prediction. The anterior cingulate cortex (ACC), involved in error monitoring, emotional salience, and attention allocation, is consistently hyperactivated in FND during motor attempts — potentially representing the sustained "prediction error" of attempted-but-unsuccessful movement. Amygdala hyperactivation — the amygdala being the brain's emotional alarm system — may mediate the emotional triggering of FND episodes in patients where emotional stimuli precipitate symptom onset.

For PNES specifically, ictal single-photon emission computed tomography (SPECT) performed during a PNES event shows activation patterns clearly distinct from epilepsy. Epileptic seizures show focal hyperperfusion originating from the seizure focus with characteristic spread; PNES ictal SPECT shows activation of emotion-processing regions (temporal-limbic system, anterior cingulate) without the characteristic epileptic spread pattern. These differences are visible on group analysis and increasingly useful in individual cases when event capture is technically successful. Critically, no FND finding on neuroimaging is explained by malingering: the brain patterns in FND patients who were strongly motivated to recover were identical to those who were not, ruling out a conscious performance of symptoms.

5. Common Presentations: Weakness, Seizures, Tremor, and More

FND encompasses a wide spectrum of neurological presentations. Any neurological symptom can present functionally, and multiple FND symptom types frequently coexist in the same patient. Understanding the range of presentations is essential because each has specific clinical features, specific examination signs, and specific treatment approaches.

Functional weakness and paralysis is the most common FND motor symptom. It may present as monoplegia (one limb), hemiplegia (arm and leg on the same side), or paraplegia (both legs). The weakness characteristically fluctuates — the patient may show profound weakness during formal examination but demonstrate preserved function in other contexts (walking differently when not being watched, using an arm while distracted). This fluctuation is not evidence of malingering; it is a feature of the functional mechanism, where attentional state profoundly influences symptom expression. The classic examination sign is Hoover's sign (Section 7). Functional weakness is associated with give-way weakness on testing and co-contraction of agonist and antagonist muscles.

Functional tremor is the most common movement disorder presenting to specialist FND clinics — in some series more common than new Parkinson's tremor diagnoses. Functional tremor is characteristically variable in frequency, amplitude, and direction, and shows the cardinal features of entrainment and distractibility (Section 7). It typically worsens with attention and observation and improves with distraction or when the patient is not monitoring the affected limb. Functional tremor may be triggered or worsened by voluntary movement of the contralateral limb. Functional gait disorder presents in several characteristic patterns: a walking-on-ice appearance with excessive caution; a dramatic lurching or swaying that is somehow caught at the last moment (rarely resulting in actual falls despite apparent near-falling); astasia-abasia (inability to walk despite preserved individual leg movements when lying); or a rocking truncal sway. Paradoxically, many patients with severe functional gait disorder can run with near-normal mechanics — this is a highly specific clinical observation.

Functional sensory disturbance most commonly presents as hemisensory loss affecting one half of the body, stopping sharply at the midline. This midline split is neurologically unusual for structural lesions because sensory representation from each side of the body overlaps at the midline (the territory of midline structures is innervated bilaterally). A sharp subjective midline split in sensory loss is therefore an internal inconsistency — a positive sign. Non-dermatomal distribution (glove-and-stocking sensory loss without peripheral nerve disease) is another feature. Functional pain and functional sensory disturbance overlap substantially with fibromyalgia, chronic pain, and complex regional pain syndrome. Functional visual symptoms include tunnel vision with the paradoxical finding that the visual field constricts as the examiner moves closer (in organic tunnel vision, the field widens with distance — the functional pattern is geometrically inconsistent with organic tunnel vision), monocular diplopia, visual blurring, and functional overlay on organic visual disease. Functional speech disorders include aphonia (complete loss of voice with preserved whispered speech — the larynx is functional for whispering but the vocal cords fail to approximate for phonation, which is internally inconsistent with structural laryngeal disease), functional dysarthria, and functional stutter.

6. Psychogenic Non-Epileptic Seizures (PNES)

Psychogenic Non-Epileptic Seizures (PNES) — also called functional seizures, non-epileptic attack disorder (NEAD), or dissociative seizures — represent the most clinically urgent and practically significant form of FND. The events resemble epileptic seizures and are frequently diagnosed and treated as epilepsy for years before the correct diagnosis is made. The consequences of misdiagnosis are severe: patients receive anti-epileptic drugs (AEDs) that are entirely ineffective for PNES while carrying substantial burdens of side effects including cognitive impairment, fatigue, mood disruption, weight changes, teratogenicity in women of childbearing age, and long-term bone density loss. Driver's license restrictions are often imposed unnecessarily. Emergency department visits are frequent and frightening, and "status epilepticus" protocols are sometimes activated for prolonged PNES events — a medically unnecessary and potentially harmful response.

The prevalence of PNES is 2–33 per 100,000 per year by different estimates. Most strikingly, 20–40% of patients admitted to epilepsy monitoring units for "refractory epilepsy" are ultimately found to have PNES rather than epilepsy on video-EEG monitoring. The mean time from first event to correct diagnosis is 7–10 years. Approximately 10–15% of patients have BOTH epilepsy and PNES — a critical co-occurrence that must always be considered when seizures seem to respond partially to AEDs or when seizures are atypical.

Several clinical features can suggest PNES rather than epilepsy, though none are individually diagnostic. PNES features include: eyes closed during the event (epileptic seizures almost universally involve eyes open and often forced eye deviation — eye closure during apparent convulsive activity is highly specific for PNES); gradual onset and offset (epileptic convulsions typically begin abruptly); prolonged duration (events lasting more than 2 minutes are unusual for uncomplicated epileptic seizures; PNES events often last 5–20 minutes; "status epilepticus" lasting 30+ minutes is a medical emergency for epilepsy but prolonged PNES events, while distressing, are not pharmacological emergencies); preserved consciousness during bilateral motor activity (in tonic-clonic seizures, consciousness is always impaired during the convulsive phase — patients who remain responsive during bilateral shaking activity are showing an FND pattern); pelvic thrusting; side-to-side head movement; ictal crying or stuttering; rapid recovery without postictal confusion (the postictal period — drowsiness, confusion, headache lasting 15–60+ minutes — is characteristic of epilepsy; rapid orientation and alertness after an event favors PNES); and a completely normal EEG recorded simultaneously with the clinical event. PNES can include shaking, jerking, stiffening, and falling — features that look exactly like epileptic seizures on superficial observation and that do NOT distinguish the two conditions without EEG.

The gold standard for PNES diagnosis is video-EEG — prolonged monitoring that simultaneously captures clinical events on video and records the EEG. Capture of a typical clinical event combined with no ictal EEG activity during that event confirms the PNES diagnosis. This requires the patient to have a typical event during the monitoring period; admission to an inpatient epilepsy monitoring unit for 3–5 days, and sometimes provocation techniques (hyperventilation, photic stimulation, suggestion), may be necessary. Once PNES is confirmed, communication of the diagnosis is itself a critical therapeutic step. A validated approach: "The good news is that your brain does not have an epileptic abnormality. The EEG during your seizure was normal — this means the events are not epilepsy. They are real events called functional seizures, caused by a different kind of brain process that we can treat effectively. The medication you have been taking does not help this type of seizure, and we will work on slowly stopping it while starting the treatments that do work." This communication, delivered with clarity and compassion, often reduces event frequency immediately — before any formal treatment has begun.

7. Positive Diagnostic Signs on Clinical Examination

A central advance in DSM-5 is the requirement for POSITIVE neurological signs that demonstrate internal inconsistency with organic neurological disease — not merely the absence of an organic explanation. These signs are not tests for "faking"; they demonstrate that the pattern of impairment is mechanistically inconsistent with structural neurological disease, which is informative regardless of the patient's intentions. The following are the most validated and practically useful.

Functional Weakness — Hoover's Sign: The most important single sign for functional leg weakness. The test exploits the physiological phenomenon of cross-extension: when one leg extends actively, the contralateral leg reflexively activates hip extension through a spinal reflex arc. Method: (1) Ask the patient to extend the "weak" leg against the examiner's resistance — test voluntary hip extension. (2) Then ask the patient to press the normal leg DOWN against the examiner's hand while the "weak" leg rests on the examiner's other palm. The cross-extension reflex automatically activates hip extension in the contralateral (weak) leg. In functional weakness: hip extension power of the "weak" leg returns to NORMAL when activated involuntarily by cross-extension, while remaining impaired on voluntary testing. In organic weakness: hip extension is impaired in BOTH conditions (structural damage cannot be remedied by a spinal reflex). Sensitivity approximately 90%, specificity approximately 99% for functional weakness (Tinazzi et al. 2021). The hip abductor sign is an analogous test for hip abduction weakness.

Functional Weakness — Co-Contraction and Give-Way: When the examiner applies resistance to limb movement in functional weakness, antagonist and agonist muscles activate simultaneously — the patient's limb "fights against itself," producing a characteristic give-way or "jelly-like" quality. This co-contraction pattern is inconsistent with organic upper or lower motor neuron weakness, where agonist activation is impaired but antagonist co-contraction does not occur in this manner. Give-way weakness — strength that tests normally, then suddenly "gives way" under sustained resistance — is another marker, though it can occur in patients who are fatigued or pain-limited and is less specific than Hoover's.

Functional Tremor — Entrainment and Distractibility: Ask the patient to tap the finger of the UNAFFECTED hand at a set rhythm while you observe the tremor in the affected hand. In functional tremor, the tremor frequency CHANGES to match the imposed tapping rhythm — it entrains to the external rhythm rather than maintaining its own independent frequency. Organic tremors (Parkinsonian, essential, cerebellar) maintain their characteristic frequency regardless of what the patient does with other limbs. Distractibility is the second cardinal sign: functional tremor reduces in amplitude when the patient performs a demanding cognitive task ("count backwards from 100 in steps of 7") or a complex movement of another limb. Organic tremors do not reduce reliably with cognitive distraction. The co-activation sign: functional tremor reduces when the examiner passively loads the limb with additional resistance, in contrast to organic tremors which are often unchanged or worsen with loading.

Functional Sensory Loss: Hemisensory loss stopping sharply at the midline is an important positive sign because the neuroanatomy of sensory representation does not produce sharp midline splits in structural disease — the territory around the midline receives bilateral representation. Non-dermatomal sensory loss (affecting a non-neurological distribution such as a glove-and-stocking pattern without peripheral neuropathy findings on EMG/NCS) is similarly inconsistent with organic sensory disease. The vibration sign: a vibrating tuning fork placed on one side of the forehead produces a report of asymmetric vibration sense — neuroanatomically impossible with skull bone conduction, which distributes vibration bilaterally, making this a highly specific positive FND sign. Functional Gait: Paradoxical improvement in gait when the patient is distracted (running, walking backwards, or performing a second cognitive task) is a reliable functional sign. Romberg testing showing dramatic sway that is somehow caught without falling — often dramatically worsening with observation — is another characteristic pattern inconsistent with organic cerebellar or vestibular disease.

8. Investigations and Gold-Standard Diagnosis

The diagnostic principle for FND has been clarified by DSM-5: diagnose with POSITIVE clinical signs, not only by the exclusion of organic disease. The historical approach — ordering ever-more-extensive investigations to "rule out everything else" before accepting FND — is now recognized as both diagnostically inferior (organic and functional disease can coexist; investigations cannot rule out FND) and potentially harmful (each normal test reinforces the patient's belief that "something is being missed" and maintains illness behavior). Positive neurological signs (Section 7) establish the diagnosis. Targeted investigation is appropriate and necessary, but the goal is to exclude conditions that have specific treatments — not to achieve diagnostic certainty through exclusion.

MRI Brain and Spine: Essential for new FND presentations to exclude structural lesions requiring treatment — multiple sclerosis, neoplasm, vascular lesions, normal-pressure hydrocephalus. MRI is typically normal in FND; this normal result should be communicated as positive news, not as absence of finding: "Your MRI is normal, which is actually good news — it means there is no structural damage to the brain. The problem is in how the brain is working, not in the brain's structure." The distinction is clinically important for patients who have been told "there's nothing wrong" and correctly feel dismissed — "how the brain works" is a real problem even when structure is intact. Video-EEG: Gold standard for PNES. Prolonged inpatient monitoring aims to capture a typical clinical event with simultaneous EEG recording. No ictal EEG activity during a clinical event consistent with PNES confirms the diagnosis. Inpatient monitoring of 3–5 days, with provocation if needed. Routine outpatient EEG is insufficient — capturing a habitual event is required. EMG and Nerve Conduction Studies: Appropriate when functional weakness must be distinguished from peripheral neuropathy, radiculopathy, or neuromuscular junction disease (myasthenia gravis). Normal EMG/NCS supports FND in the correct clinical context. Transcranial Magnetic Stimulation (TMS): Can demonstrate preserved voluntary motor pathways in functional weakness by producing movement in a "paralyzed" limb — a dramatic and often therapeutically useful demonstration that the motor system is physically intact.

What to avoid: CT as the primary brain imaging tool (poor sensitivity for most conditions, radiation burden); excessive investigation without clear clinical indication; ordering additional tests after FND diagnosis is established in response to pressure from patients who seek an organic explanation — each additional normal test reinforces the illness model and increases diagnostic uncertainty rather than resolving it. The message to patients: "We've done the key investigations needed to look for conditions that need treatment. They are reassuringly normal. The diagnosis is Functional Neurological Disorder — this is not a diagnosis of exclusion, it is a positive diagnosis based on the specific findings during your examination." When organic and functional disease genuinely coexist (which they do in perhaps 10–15% of cases), both diagnoses should be made explicitly and clearly, with specific management plans for each.

9. Treatment: Psychoeducation and Physical Therapy

The cornerstone of FND management is psychoeducation — the deliberate, compassionate, and accurate explanation of the FND diagnosis and its meaning. Psychoeducation is itself therapeutic: studies consistently find that receiving a correct and clearly communicated FND diagnosis reduces symptom frequency before any formal treatment begins. The key messages that have been validated as helpful: (1) Symptoms are REAL, not imagined or faked — many patients have been told there is nothing wrong or that the symptoms are psychiatric, and correcting this is both accurate and clinically powerful. (2) The brain has a "software" problem, not a "hardware" problem — the neural circuits are intact but are running incorrectly. (3) Recovery is possible — this is not a degenerative condition and many patients improve significantly. (4) The diagnosis is made by POSITIVE examination signs — "we found specific patterns on examination that tell us what type of disorder this is," not just "we couldn't find anything else." (5) Treatment targets the functional mechanism — physical therapy and psychological approaches address how the brain is working, not underlying structural disease. An excellent freely available patient education resource is Jon Stone's neurosymptoms.org, which provides evidence-based patient explanations written by one of the leading FND researchers.

Physical therapy (PT) is the cornerstone of treatment for functional motor symptoms — weakness, gait disorder, tremor, and movement abnormalities. FND-specific PT differs substantially from standard neurological rehabilitation, and delivering standard PT without FND adaptation may be ineffective or even counterproductive. The key principles of FND-adapted PT are: REDUCING SELF-DIRECTED ATTENTION — standard rehabilitation often asks patients to focus on the affected limb ("lift your left leg higher"), which reinforces the internal attentional feedback loop that maintains FND symptoms. FND PT uses EXTERNAL FOCUS techniques — attending to an external target, object, or goal rather than the limb itself. TASK-BASED TRAINING — goal-directed movement (reach for that glass, step to that mark) activates different cortical pathways than attempted voluntary movement and bypasses the attentional mechanisms maintaining FND. AUTOMATIC MOVEMENT is promoted over deliberate voluntary movement: walking to music, rhythmic movement, and dual-task walking recruit automatic motor programs that are less susceptible to the top-down suppression of functional weakness. GAIT RETRAINING begins with assisted walking (parallel bars, walking frame, therapist support) and progressively challenges balance and automaticity.

The evidence base for FND-specific PT includes a Cochrane review by Nielsen et al. (2015) that identified PT as beneficial for functional motor symptoms. Case series from specialist FND services show 50–70% clinically meaningful improvement with specialist FND PT. Randomized controlled trial evidence is emerging: a UK NIHR-funded RCT of FND-specific PT (UNWIND trial) is currently in follow-up. Inpatient PT programs of 3–4 weeks' duration at specialist FND units in the UK, Germany, and the United States show substantial improvement rates in motor function, maintained at follow-up. A critical management principle: FND-specific PT should NOT focus on identifying or resolving underlying psychological causes — this frames PT as a means to psychological discovery rather than a motor retraining intervention in its own right. Addressing psychological factors is important and should occur in parallel, delivered by appropriately trained clinicians, but PT itself is a legitimate and sufficient intervention for functional motor symptoms regardless of psychological comorbidity. Speech therapy using voice therapy and phonation exercises addresses functional aphonia and dysarthria with high rates of rapid improvement.

10. Psychological Treatments: CBT, EMDR, and Inpatient Rehabilitation

Cognitive-Behavioral Therapy (CBT) has the strongest evidence base among psychological interventions for FND, and randomized controlled trial evidence specifically supports CBT for PNES. The landmark Goldstein et al. trial (Lancet Psychiatry, 2020 — the CODES trial) randomized 368 adults with PNES to CBT plus standardized medical care versus standardized medical care alone. The CBT intervention was 12 individual sessions delivered by clinical psychologists trained in PNES-specific CBT. At 12-month follow-up, the CBT group showed significantly greater reduction in seizure frequency and significantly better secondary outcomes (psychological distress, quality of life, work and social functioning) compared to standard medical care alone. This is the largest RCT in FND to date and establishes CBT as the evidence-based first-line psychological treatment for PNES.

The targets of CBT for FND are specific and differ from generic CBT for anxiety or depression. They include: ILLNESS BELIEFS — what the patient believes about the cause, meaning, and prognosis of their symptoms directly influences symptom expression and recovery; FND-specific CBT identifies and gently challenges unhelpful illness beliefs while replacing them with the FND model. SAFETY BEHAVIORS — avoidance, resting, using mobility aids "just in case," reducing activities that previously triggered events — are understandable responses to frightening symptoms but maintain disability by preventing disconfirmation of feared consequences; graded engagement with avoided activities is a core CBT component. ATTENTION MANAGEMENT — reducing self-directed hypervigilance toward the affected body part or anticipated symptoms. EMOTIONAL CONTRIBUTORS — addressing depression, anxiety, and interpersonal stressors that exacerbate FND without framing these as "the cause" (which can feel invalidating). GRADED RETURN TO FUNCTION — behavioral activation, paced activity increases, resumption of work and social roles.

EMDR (Eye Movement Desensitization and Reprocessing), a trauma-focused psychological intervention with strong evidence for PTSD, is actively being researched for FND patients with significant trauma histories. The rationale is that traumatic memories may serve as templates for the brain's abnormal predictive coding in trauma-related FND, and processing those memories may modify the prediction. Randomized trials of EMDR for FND are underway but not yet published. Clinically, EMDR is appropriate for FND patients where a trauma history is identified and where the patient consents to trauma-focused work. Inpatient multidisciplinary rehabilitation at dedicated FND units represents the most intensive available treatment. These programs — based in the UK (notably at The National Hospital for Neurology and Neurosurgery, London; Leeds General Infirmary), Germany, and the United States — bring together a neurologist, physiotherapist, occupational therapist, clinical psychologist, and speech therapist for intensive 3–5 week programs. A prospective study by Maggio et al. (Eur J Neurol, 2020) found significant functional improvement at 12-month follow-up after inpatient FND rehabilitation. Patient selection, adequate program intensity, and integrated team communication are critical success factors.

Pharmacological treatment for FND is adjunctive, not primary. Anti-epileptic drugs should be gradually withdrawn under neurologist supervision in confirmed PNES patients — this is itself therapeutic, removing cognitively impairing medications that have been prescribed without benefit. SSRIs or SNRIs are appropriate for comorbid depression and anxiety — these are common in FND and should be treated in their own right — but there is no pharmacological evidence that antidepressants directly treat FND symptoms. Benzodiazepines should be used with great caution given their sedating and dependency-inducing properties and lack of FND-specific evidence. The patient community has developed strong organizations: FND Hope (fndhope.org) and FND Action provide peer support, patient education, and advocacy that significantly improve patient experience and treatment engagement.

11. Prognosis and Recovery

The prognosis of FND is more optimistic than was historically assumed, particularly with specialist treatment. Early studies from neurology outpatient settings, conducted before dedicated FND treatment pathways existed, reported poor long-term outcomes with little improvement over years. More recent studies from specialist FND services tell a more encouraging story, particularly for patients who receive early, accurate diagnosis and appropriate treatment. The most important single prognostic variable is the diagnostic delay — patients diagnosed within the first year of symptoms have substantially better outcomes than those diagnosed after 5 or more years of misdiagnosis and inappropriate treatment.

For functional weakness specifically, follow-up studies show approximately 40–50% of patients improve or recover at 5-year follow-up in referral populations. Better outcomes are consistently associated with: short illness duration at diagnosis; younger age at onset; acceptance of the FND diagnosis (patients who remain convinced of an undiscovered organic diagnosis engage less with FND-specific treatment); engagement with physical therapy and psychological treatment; absence of severe comorbid depression or personality disorder; and absence of ongoing litigation or disability compensation claims (secondary gain factors are not causal — patients with genuine functional disorders may also have legitimate disability claims — but their presence is consistently associated with worse treatment outcome).

For PNES, approximately 30% of patients become seizure-free within 2 years of diagnosis combined with CBT; an additional 30% experience substantial reduction in event frequency; approximately 40% show little change — this last group typically has severe comorbid psychiatric conditions, ongoing trauma exposure, or particularly long diagnostic delay with entrenched illness behavior. The CODES trial (Goldstein 2020) found that even patients with chronic PNES (mean duration 8 years before trial entry) showed meaningful benefit from CBT, suggesting that chronicity alone should not preclude psychological treatment. Quality of life for FND patients has historically been very poor — comparable to severe multiple sclerosis in some series — and dramatically underappreciated by clinicians who frame FND as "not real." An important finding from qualitative research is that receiving a clear, compassionate, credible FND diagnosis — even before any treatment begins — significantly improves patient wellbeing, reduces emergency department use, and initiates functional improvement. Getting the diagnosis right, and communicating it well, is itself a therapeutic act.

12. Key Research Papers

Stone J, et al. Functional weakness: clues to mechanism from the history. J Neurol Neurosurg Psychiatry. 2010;81(12):1345-1348. PMID: 20392977
Goldstein LH, et al. Cognitive-behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial. Lancet Psychiatry. 2020;7(6):491-505. PMID: 32445688
Edwards MJ, et al. A unified theory of the pathophysiology of functional neurological symptoms. Nat Rev Neurosci. 2012;13(12):803-812. PMID: 23165185
Nielsen G, et al. Physiotherapy for functional motor disorders: a consensus recommendation. J Neurol Neurosurg Psychiatry. 2015;86(10):1113-1119. PMID: 25520463
Stone J, et al. Functional neurological disorders: the new neurology of the mind. Lancet. 2012;380(9855):1716-1717. PMID: 22958002
LaFrance WC Jr, et al. Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach. Epilepsia. 2009;50(11):2527-2532. PMID: 19735396
Espay AJ, et al. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol. 2018;75(9):1132-1141. PMID: 29862443
Perez DL, et al. A review of functional neurological symptom disorder etiopathogenesis. Front Neurosci. 2018;12:29. PMID: 29434534
Maggio JB, et al. A prospective study of functional neurological disorder in an inpatient rehabilitation unit. Eur J Neurol. 2020;27(10):1947-1954. PMID: 32502284
Tinazzi M, et al. The Hoover sign: a clinical vignette. Brain Behav. 2021;11(2):e02028. PMID: 33368995
Carson A, et al. Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'. J Neurol Neurosurg Psychiatry. 2011;82(7):751-756. PMID: 20980698
Hendrickson R, et al. Incidence of psychogenic non-epileptic seizures in Rochester, Minnesota, 1980-1984. Epilepsia. 2014;55(6):894-900. PMID: 24836929

PubMed Topic Searches

Back to Table of Contents